Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | THRB | P10828 | 1/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.58 |
| ▸ | CD69 | Q07108 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.48 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.48 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.48 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29013440 | 1.00 | ALDH1A1 (0.61) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL18700558 | 1.00 | ALDH1A1 (0.61) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL29735890 | 1.00 | ALDH1A1 (0.61) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL18710872 | 1.00 | ALDH1A1 (0.61) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL7152633 | 1.00 | ALDH1A1 (0.61) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL15334201 | 1.00 | ALDH1A1 (0.61) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL317138 | 1.00 | ALDH1A1 (0.61) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL22410446 | 1.00 | ALDH1A1 (0.61) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL20552181 | 1.00 | ALDH1A1 (0.61) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL1521416 | 1.00 | ALDH1A1 (0.61) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4702138-A1 | PRODUCTION OF A NEGATIVELY CHARGED OLIGOSACCHARIDE BY A CELL | Inbiose N.V. (BE) | 2026-03-04 | — | — | EP | claimed |
| WO-2025072741-A1 | PRESERVATIVES FOR MOLECULAR SAMPLE ANALYSIS WITH SAMPLE COLLECTION DEVICES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-04-03 | — | — | WO | claimed |
| WO-2025051985-A1 | NEW METHOD FOR SYNTHESISING PHOSPHATE OLIGOSACCHARIDES OR PHOSPHATE POLYSACCHARIDES | SWEETECH (FR) | 2025-03-13 | — | — | WO | claimed |
| WO-2024223815-A1 | PRODUCTION OF A NEGATIVELY CHARGED OLIGOSACCHARIDE BY A CELL | INBIOSE N.V. (BE) | 2024-10-31 | — | — | WO | claimed |
| EP-4256049-A2 | MODULAR GLYCAN PRODUCTION WITH IMMOBILIZED BIONANOCATALYSTS | ZYMtronix Catalytic Systems, Inc. (US) | 2023-10-11 | — | — | EP | claimed |
| EP-4192946-A1 | CELLULAR PRODUCTION OF DI- AND/OR OLIGOSACCHARIDES | Inbiose N.V. (BE) | 2023-06-14 | — | — | EP | claimed |
| EP-4143328-A1 | ENZYME CASCADES BASED ON SUCROSE SYNTHASE AND PYROPHOSPHORYLASE FOR CONVERSION OF ADP TO ATP | Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen (DE) | 2023-03-08 | — | — | EP | claimed |
| EP-4045518-A1 | PRODUCTION OF BIOPRODUCT IN A HOST CELL | Inbiose N.V. (BE) | 2022-08-24 | — | — | EP | claimed |
| WO-2022119982-A2 | MODULAR GLYCAN PRODUCTION WITH IMMOBILIZED BIONANOCATALYSTS | ZYMTRONIX CATALYTIC SYSTEMS, INC. (US) | 2022-06-09 | — | — | WO | claimed |
| US-11136608-B2 | Microbial fermentation method for production of n-acetyl-d-glucosamine and/or d-glucosamine salt | SUN LAN (CN) | 2021-10-05 | — | — | US | claimed |
| US-20200308615-A1 | METHOD FOR PRODUCING N-ACETYL-D-GLUCOSAMINE AND/OR D-GLUCOSAMINE SALT BY MICROBIAL FERMENTATION | SUN LAN (CN) | 2020-10-01 | — | — | US | claimed |
| EP-3441473-A1 | METHOD FOR PRODUCING N-ACETYL-D-GLUCOSAMINE AND/OR D-GLUCOSAMINE HYDROCHLORIDE BY MICROBIAL FERMENTATION | Sun, Lan (CN) | 2019-02-13 | — | — | EP | claimed |
| EP-2566953-B1 | METHODS FOR CONTROL OF FLUX IN METABOLIC PATHWAYS THROUGH ENZYME RELOCATION | GREENLIGHT BIOSCIENCES INC (US) | 2019-01-02 | — | — | EP | claimed |
| EP-4743567-A1 | CELLULAR PRODUCTION OF LACTO-N-TRIOSE (LN3)-CONTAINING OLIGOSACCHARIDES | Inbiose N.V. (BE) | 2026-05-20 | — | — | EP | disclosed |
| EP-4731778-A2 | SIALYLTRANSFERASES FOR THE PRODUCTION OF SIALYLATED OLIGOSACCHARIDES | Inbiose N.V. (BE) | 2026-04-29 | — | — | EP | disclosed |
| EP-4702138-A1 | PRODUCTION OF A NEGATIVELY CHARGED OLIGOSACCHARIDE BY A CELL | Inbiose N.V. (BE) | 2026-03-04 | — | — | EP | disclosed |
| US-20180169015-A1 | LIPID-DERIVED NEUTRAL NANOPARTICLES | SHIRE HUMAN GENETIC THERAPIES, INC. | 2018-06-21 | — | — | US | disclosed |
| US-20180169016-A1 | LIPID-DERIVED NEUTRAL NANOPARTICLES | SHIRE HUMAN GENETIC THERAPIES, INC. | 2018-06-21 | — | — | US | disclosed |
| CN-106573962-A | Novel glycan conjugates and uses thereof | 中央研究院 | 2017-04-19 | — | — | CN | disclosed |
| US-20060141546-A1 | Bacterial test method by glycated label binding | SIEMENS HEALTHCARE DIAGNOSTICS INC. | 2006-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180169015-A1 | LIPID-DERIVED NEUTRAL NANOPARTICLES | PHOSPHO1, LPAR6, PLIN3 | ALDH1A1 4447/4885THRB 3379/4885MAPK1 4125/4885 |
| US-20180169016-A1 | LIPID-DERIVED NEUTRAL NANOPARTICLES | PHOSPHO1, LPAR6, PLIN3 | ALDH1A1 4447/4885THRB 3379/4885MAPK1 4125/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.